Directory
>
Susan Ringdal
Susan Ringdal
EVP, Strategic Planning and Global Affairs | Hikma Pharmaceuticals
United Kingdom
Susan Ringdal
Summary
Susan Ringdal is an accomplished executive with extensive experience in strategic planning and corporate affairs within the pharmaceutical industry. Currently serving as the EVP of Strategic Planning and Global Affairs at Hikma Pharmaceuticals, she has a strong background in business strategy, financial modeling, and mergers and acquisitions. Susan's career spans over two decades, including significant roles at prestigious firms such as Goldman Sachs and Morgan Stanley. Her academic credentials include an MBA from London Business School and a BA in History from Cornell University. With a proven track record in investor relations and corporate strategy, she has successfully navigated complex market landscapes. Susan is passionate about leveraging her expertise to drive innovation and sustainable growth in the pharmaceutical sector. Fluent in English, she is well-equipped to engage with diverse stakeholders across the globe. Her leadership style emphasizes collaboration and strategic foresight, making her a valuable asset to any organization.
Susan Ringdal
Work Experience
EVP, Strategic Planning and Global Affairs at
Hikma Pharmaceuticals
October 2018 - Present
Vice President, Corporate Strategy and Investor Relations at
Hikma Pharmaceuticals
November 2005 - Present
Investor Relations Manager at
Walgreens Boots Alliance
July 2003 - November 2005
Equity Research Analyst at
MORGAN STANLEY ADMINISTRADORA DE CARTEIRAS S/A
June 2000 - June 2003
Analyst at
Goldman Sachs
January 1993 - January 1997
Susan Ringdal
Education
January 1997 - January 1999
Cornell University, Bachelor Of Arts
January 1988 - January 1992
Frequently Asked Questions about Susan Ringdal
What is Susan Ringdal email address?
Susan Ringdal's primary email address is *************@hikma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Susan Ringdal work for?
Susan Ringdal is a EVP, Strategic Planning and Global Affairs at Hikma Pharmaceuticals, a company specializing in Biological products, except diagnostic.
Where Susan Ringdal graduated from?
Susan Ringdal holds a degree in from London Business School.
How can I directly contact Susan Ringdal?
To contact Susan Ringdal directly, you can use the email address *************@hikma.com. Complete contact information is available upon registration with Muraena.
Who is Susan Ringdal?
Susan Ringdal is an accomplished executive with extensive experience in strategic planning and corporate affairs within the pharmaceutical industry. Currently serving as the EVP of Strategic Planning and Global Affairs at Hikma Pharmaceuticals, she has a strong background in business strategy, financial modeling, and mergers and acquisitions. Susan's career spans over two decades, including significant roles at prestigious firms such as Goldman Sachs and Morgan Stanley. Her academic credentials include an MBA from London Business School and a BA in History from Cornell University. With a proven track record in investor relations and corporate strategy, she has successfully navigated complex market landscapes. Susan is passionate about leveraging her expertise to drive innovation and sustainable growth in the pharmaceutical sector. Fluent in English, she is well-equipped to engage with diverse stakeholders across the globe. Her leadership style emphasizes collaboration and strategic foresight, making her a valuable asset to any organization.
Susan`s contact details
*************@hikma.com
Colleagues
Vice President
Associate Vice President, Production, Engineering and Maintenance
Vice President Group Business Development & Alliances
Vice President & General Manager
Associate Vice President of Commercial Operations
Associate Vice President | Business Development, Product Selection, Strategy
Chief Executive Officer
Chairman of the Board of Directors
Senior Vice President, General Manager - Generics Operations
Chief Commercial Officer, US Generics